Top View
- Prediction by Pharmacogenetics of Safety and Efficacy of Non-Steroidal Anti- Inflammatory Drugs: a Review
- Genetic Polymorphisms of CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 in Vietnamese-Koreans
- Cytochrome P450 Genotyping
- Warfarin Sensitivity (CYP2C8, CYP2C9, CYP4F2, VKORC1) Genotyping
- Functional Assessment of 12 Rare Allelic CYP2C9 Variants Identified in a Population of 4773 Japanese Individuals
- Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs
- The Inhibition of CYP1A2, CYP2C9, and CYP2D6 by Pterostilbene in Human Liver Microsomes
- Pharmacogenetics of Nonsteroidal Anti-Inflammatory Drugs
- CYP2C9 Functional Haplotypes
- Pharmacogenomics of CYP2C9: Functional and Clinical Considerations†
- Individuals with CYP2C8 and CYP2C9 Reduced Metabolism Haplotypes Self-Adjusted Ibuprofen Dose in the Coriell Personalized Medicine Collaborative Stefan C
- Strong and Selective Inhibitory Effects of the Biflavonoid Selamariscina A
- CYP2C19, CYP2D6, CYP2C9, and VKORC1 Genetic Testing (L35072)
- Factors Influencing the Magnitude and Clinical Significance of Drug Interactions Between Azole Antifungals and Select Immunosuppressants
- A Review of the Important Role of CYP2D6 in Pharmacogenomics
- The Role of Vitamin K in Cholestatic Liver Disease
- Genetic Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard Populations: a Comparative Study
- Comparative Analysis of Peritoneum and Tumor Eicosanoids and Pathways in Advanced Ovarian Cancer Ralph S
- CYP2C19 and CYP2C9: New Aspects of Pharmacogenetics and Transcriptional Regulation CYP2C19 and CYP2C9: Newof Pharmacogenetics Aspects and Transcriptional Regulation
- Bile Acids, Nuclear Receptors and Cytochrome P450
- Functional Characterization of 32 CYP2C9 Allelic Variants
- The Cytochrome P450 Slow Metabolizers CYP2C9*2 and CYP2C9*3 Directly Regulate Tumorigenesis Via Reduced Epoxyeicosatrienoic Acid Production
- Crystal Structure of the Human Prostacyclin Synthase
- Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration
- Warfarin Therapy and the Genotypes CYP2C9 and VKORC1 Laura Dean, MD1 Created: March 8, 2012; Updated: June 8, 2016
- Human Lanosterol 14-Alpha Demethylase (CYP51A1) Is a Putative Target for Natural Flavonoid Luteolin 7,30-Disulfate
- Bile Acids, Nuclear Receptors and Cytochrome P450
- Alternative Splicing in the Cytochrome P450 Superfamily Expands Protein Diversity to Augment Gene Function and Redirect Human Drug Metabolism S
- Effect of Iguratimod on Diclofenac Metabolism by CYP2C9 in Rats and Human Recombinant CYP2C9 Yeast Cells
- Multi-Ethnic Distribution of Clinically Relevant CYP2C Genotypes and Haplotypes
- CYP2R1 Is a Major, but Not Exclusive, Contributor to 25-Hydroxyvitamin D Production in Vivo
- Celecoxib Therapy and CYP2C9 Genotype
- The CYP2R1 Enzyme: Structure, Function, Enzymatic Properties and Genetic Polymorphism
- CYP2C9 English
- The Influence of Biological Sex and Sex Hormones on Bile Acid
- Characterization of the Most Common CYP2C9 and CYP2C19 Allelic Variants in the Population from the Republic of Macedonia
- Development of a Fluorescence-Based Trypanosoma Cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
- CYP2C8 and CYP2C9 *1C/*1C * *2/*2 * Patient
- Prostacyclin Synthase and Arachidonate 5-Lipoxygenase Polymorphisms and Risk of Colorectal Polyps
- From Design to in Vivo Active Organometallic- Containing Antimycotic Agents
- Association of CYP2C92 with Bosentaninduced Liver Injury